The Matrix Revolutions
- 30 March 2007
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 100 (6) , 749-750
- https://doi.org/10.1161/01.res.0000263398.47653.ef
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cellsCardiovascular Research, 2006
- Estradiol Enhances Recovery After Myocardial Infarction by Augmenting Incorporation of Bone Marrow–Derived Endothelial Progenitor Cells Into Sites of Ischemia-Induced Neovascularization via Endothelial Nitric Oxide Synthase–Mediated Activation of Matrix Metalloproteinase-9Circulation, 2006
- Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Angiogenic Factors Reconstitute Hematopoiesis by Recruiting Stem Cells from Bone Marrow MicroenvironmentAnnals of the New York Academy of Sciences, 2003
- Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1—matrix metalloproteinase following acute hindlimb ischemiaJournal of Surgical Research, 2003
- Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive LabelingCirculation, 2003
- Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrixBlood, 2003
- Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-LigandCell, 2002
- Differential MMP and TIMP production by human marrow and peripheral blood CD34+ cells in response to chemokinesExperimental Hematology, 2000
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisNature Cell Biology, 2000